<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on November 19, 2026 at 7:39 pm by All in One SEO Pro v5.0.5.1 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://sakaradigital.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Sakara Digital</title>
		<link><![CDATA[https://sakaradigital.com]]></link>
		<description><![CDATA[Sakara Digital]]></description>
		<lastBuildDate><![CDATA[Fri, 20 Nov 2026 00:39:13 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://sakaradigital.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://sakaradigital.com/blog/fda-distributed-manufacturing-rule-quality-systems/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/fda-distributed-manufacturing-rule-quality-systems/]]></link>
			<title>One Registration, Many Sites: What FDA&#8217;s Distributed Manufacturing Rule Asks of Your Quality Systems</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:39:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/data-catalog-selection-life-sciences-beyond-features/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/data-catalog-selection-life-sciences-beyond-features/]]></link>
			<title>Data Catalog Selection for Life Sciences: Beyond the Feature Grid</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:38:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/shadow-ai-discovery-remediation-regulated-life-sciences/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/shadow-ai-discovery-remediation-regulated-life-sciences/]]></link>
			<title>Shadow AI Discovery and Remediation in Regulated Life Sciences</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:38:43 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/board-ready-ai-strategy-presentation-template/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/board-ready-ai-strategy-presentation-template/]]></link>
			<title>The Board-Ready AI Strategy Presentation Template</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:38:14 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/federated-learning-pharma-consortia-lessons-recent-deals/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/federated-learning-pharma-consortia-lessons-recent-deals/]]></link>
			<title>Federated Learning Across Pharma Consortia: Lessons From Recent Deals</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:37:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/it-modernization-roadmap-mid-size-pharma/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/it-modernization-roadmap-mid-size-pharma/]]></link>
			<title>IT Modernization Roadmap for Mid-Size Pharma and Biotech</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:37:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/eu-pharma-package-2026-drug-approval-framework-pharma-it/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/eu-pharma-package-2026-drug-approval-framework-pharma-it/]]></link>
			<title>EU Pharma Package 2026: What the New Drug Approval Framework Means for Global Pharma IT Teams</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:37:23 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/ai-build-vs-buy-hidden-costs-gxp/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/ai-build-vs-buy-hidden-costs-gxp/]]></link>
			<title>AI Made Building Software Cheap. It Did Not Make Owning a GxP System Cheap.</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:37:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/batch-genealogy-biologics-lot-traceability/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/batch-genealogy-biologics-lot-traceability/]]></link>
			<title>Batch Genealogy for Biologics: Tracing a Lot Back Through Bulk and Cell Bank</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:36:49 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/ai-steering-committee-charter-mid-cap-biotech/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/ai-steering-committee-charter-mid-cap-biotech/]]></link>
			<title>The AI Steering Committee Charter for Mid-Cap Biotech</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:36:27 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/site-payment-automation-clinical-trials-pilot-framework/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/site-payment-automation-clinical-trials-pilot-framework/]]></link>
			<title>Site Payment Automation in Clinical Trials: A Pilot Program Framework</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:36:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/internal-audit-program-analytics-risk-based-scheduling/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/internal-audit-program-analytics-risk-based-scheduling/]]></link>
			<title>Internal Audit Program Analytics: Scheduling Audits by Risk, Not Calendar</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:36:06 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/talent-strategy-pre-revenue-biotech-hire-vs-contract/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/talent-strategy-pre-revenue-biotech-hire-vs-contract/]]></link>
			<title>Talent Strategy for Pre-Revenue Biotech: When to Hire vs. Contract</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:35:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/quality-metrics-dashboard-drives-investigations-closure/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/quality-metrics-dashboard-drives-investigations-closure/]]></link>
			<title>The Quality Metrics Dashboard That Actually Drives Investigations to Closure</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:35:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/fda-digital-health-precertification-lessons-learned-path-forward-software-developers/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/fda-digital-health-precertification-lessons-learned-path-forward-software-developers/]]></link>
			<title>FDA Digital Health Precertification: Lessons Learned and the Path Forward for Software Developers</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:35:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/quality-it-handoff-validation-delays/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/quality-it-handoff-validation-delays/]]></link>
			<title>The Quality and IT Handoff That Causes Most Validation Delays</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:35:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/quality-agreement-clauses-break-when-you-digitize/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/quality-agreement-clauses-break-when-you-digitize/]]></link>
			<title>The Quality Agreement Clauses That Break When You Digitize</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:35:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/job-architecture-data-ai-roles-life-sciences/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/job-architecture-data-ai-roles-life-sciences/]]></link>
			<title>Job Architecture for Data and AI Roles in Life Sciences</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:35:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/governing-prompt-libraries-reusable-ai-assets-pharma/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/governing-prompt-libraries-reusable-ai-assets-pharma/]]></link>
			<title>Governing Prompt Libraries and Reusable AI Assets</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:35:14 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/fractional-chief-ai-officer-engagement-model-biotech/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/fractional-chief-ai-officer-engagement-model-biotech/]]></link>
			<title>The Fractional Chief AI Officer Engagement Model for Biotech</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:35:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/quality-rules-engine-selection-pharma-framework/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/quality-rules-engine-selection-pharma-framework/]]></link>
			<title>Quality Rules Engine Selection for Pharma: A Decision Framework</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:34:59 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/synthetic-data-pharma-rd-governance/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/synthetic-data-pharma-rd-governance/]]></link>
			<title>Synthetic Data in Pharma R&#038;D: Use Cases, Risks, and Governance</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:34:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/cross-functional-operating-models-digital-pharma-2/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/cross-functional-operating-models-digital-pharma-2/]]></link>
			<title>Cross-Functional Operating Models for Digital Pharma: Breaking Silos Between IT, Quality, and Operations</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:34:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/atmp-manufacturing-automation/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/atmp-manufacturing-automation/]]></link>
			<title>ATMP Manufacturing Automation: Scaling Cell and Gene Therapy Production Through Digital Innovation</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:34:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/fda-precheck-pilot-program-facility-engagement-pharma-manufacturing/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/fda-precheck-pilot-program-facility-engagement-pharma-manufacturing/]]></link>
			<title>FDA PreCheck Pilot Program: How Early Facility Engagement Accelerates Domestic Pharma Manufacturing</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:34:08 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/drift-monitoring-continued-process-verification/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/drift-monitoring-continued-process-verification/]]></link>
			<title>Drift Monitoring as a Continued Process Verification Activity</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:33:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/data-quality-regulatory-labeling-recall-source/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/data-quality-regulatory-labeling-recall-source/]]></link>
			<title>Data Quality in Regulatory Labeling: A Source of Recalls Nobody Tracks</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:33:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/continuous-inspection-readiness-ai-what-to-automate/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/continuous-inspection-readiness-ai-what-to-automate/]]></link>
			<title>Continuous Inspection Readiness With AI: What to Automate and What to Keep Human</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 00:33:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/investigator-site-portal-consolidation-case-study-analysis/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/investigator-site-portal-consolidation-case-study-analysis/]]></link>
			<title>Investigator Site Portal Consolidation: A Case Study Analysis</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 21:05:59 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/fda-annual-report-cmc-changes/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/fda-annual-report-cmc-changes/]]></link>
			<title>FDA Annual Reports for CMC Changes: Collecting the Data as Changes Happen</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 21:05:49 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/sakara-signals-august-1-2025/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/sakara-signals-august-1-2025/]]></link>
			<title>Sakara Signals | August 1, 2025</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 21:05:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/sakara-signals-august-15-2025-biotech-in-balance-innovation-integrity-and-impact/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/sakara-signals-august-15-2025-biotech-in-balance-innovation-integrity-and-impact/]]></link>
			<title>Sakara Signals | August 15, 2025 &#8211; Biotech in Balance: Innovation, Integrity, and Impact</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 21:05:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/econsent-pediatric-trials-lessons-three-2025-programs/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/econsent-pediatric-trials-lessons-three-2025-programs/]]></link>
			<title>eConsent for Pediatric Trials: Lessons From Three 2025 Programs</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 21:04:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/eqms-module-vs-best-of-breed-tool/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/eqms-module-vs-best-of-breed-tool/]]></link>
			<title>Choosing Between an eQMS Module and a Best-of-Breed Tool</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 21:04:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/sequencing-data-work-ai-roadmap/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/sequencing-data-work-ai-roadmap/]]></link>
			<title>Sequencing Data Work Against an AI Roadmap Without Stalling Both</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 21:04:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/master-data-quality-pilots-business-case/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/master-data-quality-pilots-business-case/]]></link>
			<title>The Hidden Cost of Bad Master Data: Four Pilots to Build Your Business Case</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 21:04:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/ai-governance-committee-fast-approval/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/ai-governance-committee-fast-approval/]]></link>
			<title>Building an AI Governance Committee That Approves Use Cases in Weeks, Not Quarters</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 21:04:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/commercial-biopharma-ai-ready-data/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/commercial-biopharma-ai-ready-data/]]></link>
			<title>Why Commercial Biopharma Cannot Scale AI on Its Current Data</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 21:04:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/migrating-ai-models-between-vendors/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/migrating-ai-models-between-vendors/]]></link>
			<title>Migrating AI Models Between Vendors: The Validation and Data Integrity Questions</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 21:03:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/idmp-product-master-data-cleanup/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/idmp-product-master-data-cleanup/]]></link>
			<title>Product Master Data for IDMP: Cleaning Your Data While the Timeline Settles</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 21:03:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/compliance-training-human-centered-design/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/compliance-training-human-centered-design/]]></link>
			<title>Why Compliance Training Fails Without Human-Centered Design</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 21:03:27 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/health-authority-query-tracking/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/health-authority-query-tracking/]]></link>
			<title>Health Authority Questions Across Markets: Tracking Queries and Responses in One Place</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 21:03:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/the-velocity-of-lasting-change-part-1-the-funeral-of-innovation/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/the-velocity-of-lasting-change-part-1-the-funeral-of-innovation/]]></link>
			<title>The Velocity of Lasting Change, Part 1 &#8211; The Funeral of Innovation</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 21:03:06 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/understanding-ai-maturity-part-5-stage-4-enterprise-ecosystems/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/understanding-ai-maturity-part-5-stage-4-enterprise-ecosystems/]]></link>
			<title>Understanding AI Maturity: Part 5 – Stage 4: Enterprise Ecosystems</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 21:02:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/quality-system-needs-tune-up/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/quality-system-needs-tune-up/]]></link>
			<title>5 Signs Your Quality System Needs a Tune-Up</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 21:02:49 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/black-mesa-gaip-progress-report-latest-draft/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/black-mesa-gaip-progress-report-latest-draft/]]></link>
			<title>Black Mesa GAIP Progress Report: What Is Public So Far and What It Signals</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 21:02:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/adaptive-clinical-trial-designs-rare-disease-math/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/adaptive-clinical-trial-designs-rare-disease-math/]]></link>
			<title>Adaptive Clinical Trial Designs in Rare Disease: When the Math Works</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 21:02:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/clinical-supply-label-data-quality/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/clinical-supply-label-data-quality/]]></link>
			<title>Clinical Supply Label Data: The Fields That Cause Mislabeled Kits</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 21:01:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/pics-pi-006-4-qualification-validation-changes/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/pics-pi-006-4-qualification-validation-changes/]]></link>
			<title>PIC/S PI 006-4 Is in Force: What the Revised Qualification and Validation Recommendations Change</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 20:39:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/eu-ai-act-ai-literacy-gxp-staff/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/eu-ai-act-ai-literacy-gxp-staff/]]></link>
			<title>AI Literacy Training for GxP Staff: What the EU AI Act Still Requires After the Digital Omnibus</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 20:39:40 +0000]]></pubDate>
		</item>
				</channel>
</rss>
